CADAS138 stands out as a novel therapeutic target in the realm of chronic illnesses. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to alleviate disease progression. Researchers are actively exploring the underlying pathways of CADAS138 in disease pathogenesis, paving the way for the development of novel th… Read More